Home
Home

Regeneron

FDA Sprinkles Some Rain On the PCSK9 Inhibitor Parade

FDA Sprinkles Some Rain On the PCSK9 Inhibitor Parade
Forbes

FDA asks Sanofi, Regeneron to assess cholesterol drug's cognitive risks

FDA asks Sanofi, Regeneron to assess cholesterol drug's cognitive risks
Yahoo/Reuters

Biotech Stock Roundup: InterMune Grabs Headlines with Impressive Data

Biotech Stock Roundup: InterMune Grabs Headlines with Impressive Data
Yahoo/Zacks.com

Regeneron Chief Leonard Schleifer Becomes A Billionaire After 25 Year Search For New Drugs Comment Now Follow Comments

Regeneron Chief Leonard Schleifer Becomes A Billionaire After 25 Year Search For New Drugs
Forbes

One Reason the Biotech Boom Won’t Turn to Bust

One Reason the Biotech Boom Won’t Turn to Bust
Barron's

No Looking Back for Regeneron's Eylea

No Looking Back for Regeneron's Eylea
Yahoo/Zacks.com

Biotech: Too Big for Its Britches?

Biotech: Too Big for Its Britches?
Barron's

Biotech Stock Roundup: Regeneron's Eylea Impresses, Gilead Files for Next HCV Drug

Biotech Stock Roundup: Regeneron's Eylea Impresses, Gilead Files for Next HCV Drug
Yahoo/Zacks.com

Breakout Week for Biotech? Comment Now Follow Comments

Breakout Week for Biotech? Comment Now Follow Comments
Forbes

Why Regeneron Pharmaceuticals Has A Bright Future Ahead

Why Regeneron Pharmaceuticals Has A Bright Future Ahead
Seeking Alpha